[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$crvs

Corvus Pharmaceuticals presents promising Phase X data for Soquelitinib, sparking investor interest despite a recent net loss. Analyst upgrades and positive social media sentiment highlight potential growth opportunities.

About $crvs

Corvus Pharmaceuticals is a biotechnology company focused on developing therapies for cancer and inflammatory diseases.

Insights

• $crvs creators is up XXXXX% from the previous week.
• $crvs engagements is up XXXXXX% from the previous week.
• $crvs posts created is up XXXXX% from the previous week.

Engagements: XXXXXX (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +211%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX +74%
1-Year High: XXXXXXX on 2025-01-02
1-Year Low: XXXXX on 2025-03-16

Engagements by network (24h): X: XXXXXX

Mentions: XX (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX +4.70%
X Month: XXX -XX%
X Months: XXXXX -XX%
X Year: XXXXX -XX%
1-Year High: XXX on 2024-12-13
1-Year Low: XX on 2025-12-07

Mentions by network (24h): X: XXX

Creators: XX (24h)

Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $crvs in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: XX
X Week: XX +11%
X Month: XXX -XX%
X Months: XXXXX +97%
X Year: XXXXX +232%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-02-10

The most influential creators that mention $crvs in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@HOThomasWPhelps	X	XXXXX	XX	XXXXX
@semodough	X	XXXXXX	X	XXXXX
@OzmosiHealth	X	XXXXX	X	XXX
@Fredbenz0	X	XXXXX	X	XXX
@TheOptionsBull2	X	XXX	X	XXX
@Pharmdca	X	XXXXXXX	X	XXX
@mtheory11bio	X	XXXXX	X	XXX
@MarketRebels	X	XXXXXXX	X	XXX
@financebully	X	XXX	X	XXX
@doepke_michel	XX	XXXXX	X	XX

View More

Sentiment: XX%

Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-02-09
1-Year Low: XX% on 2025-03-17

Most Supportive Themes:

• Pipeline Milestones and Data Readouts: (40%) Corvus Pharmaceuticals is advancing its lead asset, Soquelitinib, with Phase X extension cohorts completed and Phase 2/3 trials on track, generating anticipation for upcoming data releases.
• Analyst Coverage and Price Targets: (30%) Barclays initiated coverage with an Overweight rating and a $XX price target, signaling positive sentiment and potential upside from institutional analysis.

Most Critical Themes:

• Net Loss and Financial Performance: (10%) Corvus Pharmaceuticals reported a net loss of $10.2M in Q3, a significant increase from the previous year, raising concerns about financial sustainability.

Top $crvs Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$crvs PTCL presentation G3+ AE table: infection liver failure cardiac failure anemia etc. Didn't seem that clean as advertised Anyone close to this & have a view"
X Link @But_The_Comps 2025-12-10T07:13Z XXX followers, XXX engagements

"$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:"
X Link @OzmosiHealth 2025-12-09T21:21Z 3014 followers, XXX engagements

"$CVS $MRNA $CNM $ACHR $OCUL $DECK $MBLY $TECH $EXE $CRVS $PBF $SNAP $HBM $OPEN $TWLO $PAAS $S $PSKY $AM $TEX $ON $AEO $KNX $ZM $TOL 🎯TopUnusual Report-Part X 🎯Verified Dec XX Data ⚠These 72of8000+ Verified & Represent Top Bullish Unusual Options Stocks"
X Link @Fredbenz0 2025-12-09T21:03Z 2692 followers, XXX engagements

"$CRSP $CRVS Guys Don't miss the next move in a few hours. =-"
X Link @Skwld69988 2025-12-09T16:06Z X followers, XXX engagements